1998
DOI: 10.1038/sj.onc.1202173
|View full text |Cite
|
Sign up to set email alerts
|

Genetic analysis of mammalian G-protein signalling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
36
0

Year Published

1999
1999
2018
2018

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 44 publications
(37 citation statements)
references
References 38 publications
1
36
0
Order By: Relevance
“…activating adenylyl cyclases) highly related to G␣olf. Such compensatory mechanisms have previously been observed between G␣ subunits (Offermanns and Simon, 1998).…”
Section: Research Articlesupporting
confidence: 64%
“…activating adenylyl cyclases) highly related to G␣olf. Such compensatory mechanisms have previously been observed between G␣ subunits (Offermanns and Simon, 1998).…”
Section: Research Articlesupporting
confidence: 64%
“…Surprisingly, G␣ 11 , even though expressed at levels similar to those of other G proteins, was most potent in stimulating the ERK cascade. Considering the high degree of redundancy of G q and G 11 in signal transduction (23,46), further studies are needed to judge whether the apparently stronger ERK activation by G 11 reflects a property that distinguishes it from G q in vivo. However, we cannot entirely exclude that slight differences in the expression levels of G proteins or an increased apoptosis induced by some constitutive active mutants (15) might also have an impact on their ability to activate ERK in these assays.…”
Section: Discussionmentioning
confidence: 99%
“…6,13,14 In the present study, we investigated the function of the peripheral cannabinoid receptor when overexpressed on myeloid cells (ie, 32D/G-CSF-R [granulocyte colony-stimulating factor receptor]) in which we overexpressed exon-1B/exon-2 Cb2 splice variant and a myeloid leukemia cell line containing a virus insertion in the Cb2 locus, NFS 78. We also wished to determine which of the large panel of Cb2 ligands that have been identified previously is the true agonist of the receptor.…”
mentioning
confidence: 99%